SEC Filings

Investor RelationsClick here to open mobile navigation

1875091NASDAQ: NRSN
YearTrailing 12-MonthsCalendar Year 2024Calendar Year 2023Calendar Year 2022Calendar Year 2021
ViewAll FilingsAnnual FilingsCurrent FilingsRegistration StatementsOther
FormDescriptionDateFormat
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsDec 30, 2021Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in HTML.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in DOC file.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in PDF file.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in XLS file.
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsDec 23, 2021Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in HTML.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in DOC file.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in PDF file.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in XLS file.
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsDec 20, 2021Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in HTML.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in DOC file.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in PDF file.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in XLS file.
EFFECTNotice from the SEC of registration effectivenessDec 8, 2021Open Notice from the SEC of registration effectiveness in HTML.Open Notice from the SEC of registration effectiveness in DOC file.Open Notice from the SEC of registration effectiveness in PDF file.Open Notice from the SEC of registration effectiveness in XLS file.
CERTCERTDec 8, 2021Open CERT in HTML.Open CERT in DOC file.Open CERT in PDF file.Open CERT in XLS file.
CORRESPCorrespondence from the Filer to the SECDec 6, 2021Open Correspondence from the Filer to the SEC in HTML.Open Correspondence from the Filer to the SEC in DOC file.Open Correspondence from the Filer to the SEC in PDF file.Open Correspondence from the Filer to the SEC in XLS file.
CORRESPCorrespondence from the Filer to the SECDec 6, 2021Open Correspondence from the Filer to the SEC in HTML.Open Correspondence from the Filer to the SEC in DOC file.Open Correspondence from the Filer to the SEC in PDF file.Open Correspondence from the Filer to the SEC in XLS file.
FWPFree Writing ProspectusDec 6, 2021Open Free Writing Prospectus in HTML.Open Free Writing Prospectus in DOC file.Open Free Writing Prospectus in PDF file.Open Free Writing Prospectus in XLS file.
CORRESPCorrespondence from the Filer to the SECNov 19, 2021Open Correspondence from the Filer to the SEC in HTML.Open Correspondence from the Filer to the SEC in DOC file.Open Correspondence from the Filer to the SEC in PDF file.Open Correspondence from the Filer to the SEC in XLS file.
UPLOADCorrespondence from the SEC to the FilerNov 16, 2021Open Correspondence from the SEC to the Filer in HTML.Open Correspondence from the SEC to the Filer in DOC file.Open Correspondence from the SEC to the Filer in PDF file.Open Correspondence from the SEC to the Filer in XLS file.
FWPFree Writing ProspectusNov 10, 2021Open Free Writing Prospectus in HTML.Open Free Writing Prospectus in DOC file.Open Free Writing Prospectus in PDF file.Open Free Writing Prospectus in XLS file.
CORRESPCorrespondence from the Filer to the SECNov 4, 2021Open Correspondence from the Filer to the SEC in HTML.Open Correspondence from the Filer to the SEC in DOC file.Open Correspondence from the Filer to the SEC in PDF file.Open Correspondence from the Filer to the SEC in XLS file.
CORRESPCorrespondence from the Filer to the SECOct 18, 2021Open Correspondence from the Filer to the SEC in HTML.Open Correspondence from the Filer to the SEC in DOC file.Open Correspondence from the Filer to the SEC in PDF file.Open Correspondence from the Filer to the SEC in XLS file.
UPLOADCorrespondence from the SEC to the FilerOct 15, 2021Open Correspondence from the SEC to the Filer in HTML.Open Correspondence from the SEC to the Filer in DOC file.Open Correspondence from the SEC to the Filer in PDF file.Open Correspondence from the SEC to the Filer in XLS file.
DRS/ADRS/AOct 7, 2021Open DRS/A in HTML.Open DRS/A in DOC file.Open DRS/A in PDF file.Open DRS/A in XLS file.
DRSLTRDRSLTROct 6, 2021Open DRSLTR in HTML.Open DRSLTR in DOC file.Open DRSLTR in PDF file.Open DRSLTR in XLS file.
UPLOADCorrespondence from the SEC to the FilerOct 1, 2021Open Correspondence from the SEC to the Filer in HTML.Open Correspondence from the SEC to the Filer in DOC file.Open Correspondence from the SEC to the Filer in PDF file.Open Correspondence from the SEC to the Filer in XLS file.
DRSLTRDRSLTRSep 21, 2021Open DRSLTR in HTML.Open DRSLTR in DOC file.Open DRSLTR in PDF file.Open DRSLTR in XLS file.
DRS/ADRS/ASep 21, 2021Open DRS/A in HTML.Open DRS/A in DOC file.Open DRS/A in PDF file.Open DRS/A in XLS file.
UPLOADCorrespondence from the SEC to the FilerSep 3, 2021Open Correspondence from the SEC to the Filer in HTML.Open Correspondence from the SEC to the Filer in DOC file.Open Correspondence from the SEC to the Filer in PDF file.Open Correspondence from the SEC to the Filer in XLS file.
DRSDRSAug 10, 2021Open DRS in HTML.Open DRS in DOC file.Open DRS in PDF file.Open DRS in XLS file.
DRSLTRDRSLTRAug 9, 2021Open DRSLTR in HTML.Open DRSLTR in DOC file.Open DRSLTR in PDF file.Open DRSLTR in XLS file.

Home

Research

About

Publications

© NeuroSense Therapeutics 2024  All Rights Reserved | Privacy Policy | Terms | Accessibility

Skip to content